Shanghai, China

Zhengsheng Zhan

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Chinese Academy of Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhengsheng Zhan. Retrieved from https://idiyas.com/inventor/zhengsheng-zhan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhengsheng Zhan: Innovator in CSF1R Kinase Inhibitors

Introduction

Zhengsheng Zhan is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmacology, particularly in the development of kinase inhibitors. His work focuses on innovative solutions for treating diseases related to the CSF1R kinase signal transduction pathway.

Latest Patents

Zhan holds a patent for a CSF1R kinase inhibitor and its use in pharmaceuticals. This patent outlines the application of a CSF1R kinase inhibitor compound or a pharmaceutically acceptable salt in the preparation of drugs aimed at treating diseases associated with the CSF1R kinase signal transduction pathway. Additionally, it includes the use of these compounds for regulating immunization.

Career Highlights

Zhengsheng Zhan is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential impact on therapeutic strategies in immunology and oncology.

Collaborations

Zhan collaborates with notable colleagues, including Jian Ding and Wenhu Duan, who contribute to his research endeavors and enhance the scope of his projects.

Conclusion

Zhengsheng Zhan is a key figure in the development of CSF1R kinase inhibitors, with a focus on innovative treatments for various diseases. His contributions to the field are paving the way for advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…